A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod.
MUSK, a vision-language model, enhances cancer diagnosis by integrating multimodal data, outperforming existing methods in prognosis and treatment predictions.
A colorectal cancer (CRC) screening public health initiative launched in Harbin, China has attracted about 830,000 participants for registration. The project utilizes fecal DNA methylation testing ...